Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.
about
[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis.Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer TreatmentThe prognostic value of 18F-FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases.Radiomics analysis of pre-treatment [F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment
P2860
Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Metabolic tumor volume and tot ...... Vmax, SUVpeak, and RECIST 1.0.
@en
type
label
Metabolic tumor volume and tot ...... Vmax, SUVpeak, and RECIST 1.0.
@en
prefLabel
Metabolic tumor volume and tot ...... Vmax, SUVpeak, and RECIST 1.0.
@en
P2093
P2860
P50
P1476
Metabolic tumor volume and tot ...... Vmax, SUVpeak, and RECIST 1.0.
@en
P2093
Constantinos T Sofocleous
Mithat Gonen
Richard K Do
Sirish Kishore
Somali Gavane
Waleed Shady
P2860
P304
P356
10.1016/J.EJRAD.2016.03.029
P577
2016-03-31T00:00:00Z